Health Catalyst, Inc. (HCAT)
Healthcare
- Fundamental
- 2
- Sentiment
- 2
- Technical
- 2
Do Nothing: fundamentalScore 2 and qualitativeScore 2 are both below the required floor of 3 and 20-day average dollar volume of ~$0.57M (~$0.81M over the last three sessions) is far below the $5M liquidity floor; the chart offers only a countertrend bounce (price < SMA50 with MACD < 0) and a marginal ~1.04 R/R breakout stop, so neither entry type qualifies.
Company overview
Health Catalyst, Inc. provides data and analytical technologies to healthcare providers, offering a comprehensive platform for data analytics, AI integration, and population health management. The company also focuses on financial insights and quality improvement in healthcare, facilitating a national data ecosystem for collaborative insights. Founded in 2008 and based in South Jordan, Utah, it was formerly known as HQC Holdings, Inc.
Fundamental
weakHealth Catalyst's fundamentals are weak, with declining revenue and EBITDA, and ongoing management turnover.
Cheap but shrinking: a net-cash balance sheet and rock-bottom EV/sales mask a 2026 revenue and Adjusted EBITDA collapse, continuing goodwill write-downs and repeated CEO turnover. Fundamentals read as weak and still deteriorating - not actionable on a short horizon.
Sentiment
weakSentiment is neutral with no forward-dated catalysts or significant retail engagement.
HCAT's only actionable catalyst is the trailing Q3 2026 earnings print (announced, 2026-11-05, partially priced), whose reception was genuinely two-sided — revenue and adjusted EBITDA above the reaffirmed guidance range and a now debt-free balance sheet against a GAAP net loss, an EPS miss versus consensus and elevated client churn — netting to a neutral direction; the sentiment delta is determinate but flat (baseline +0.012 → scoring 0.00), and the Red-Flag Screen is clean with no severe or moderate flag fired. With no forward-dated catalyst inside 30 days, a flat delta in a measured-but-thin window, and retail unmeasured after a Reddit access block, the setup is post-event digestion rather than a mixed or forming one.
Technical
weakThe stock is experiencing a countertrend bounce within a downtrend, with no trend-aligned setup.
Chart quality score 2 (bounce-only). Price 1.51 is above the short-term EMA9 1.49 / WMA9 1.46 / DEMA14 1.44 / TEMA14 1.41 but below SMA20 1.60, WMA21 1.54, EMA21 1.57, SMA200 1.68 and SMA50 1.69. RSI14 45.1 has recovered from 34.9 on 2026-11-12 but remains below 50, Williams %R -66.0 is neutral, MACD -0.08/-0.06 with histogram -0.02 is negative and still under its signal, and ADX14 17.0 signals no trend. ATR14 0.13 is a high 8.6% of price, Friday's 465K shares produced only ~$0.70M of turnover, and the 20-session average dollar volume is ~$0.57M. The action is Do Nothing: fundamentalScore 2 and qualitativeScore 2 both fail the ≥3 override floors and liquidity fails the $5M floor; setupType is no_setup because no actionable trade exists.
You’re looking at 2026-11-14 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.

